XANTHINE-SUBSTITUTED ALKYNYL CARBAMATES/REVERSE CARBAMATES AS A2B ANTAGONISTS
申请人:Lewis and Clark Pharmaceuticals, Inc.
公开号:US20160297819A1
公开(公告)日:2016-10-13
The present invention provides xanthine-substituted alkynyl carbamates/reverse carbamates and derivatives thereof and pharmaceutical compositions containing the same that are selective antagonists of A
2B
adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A
2B
adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
申请人:Wang Guoquan
公开号:US20070105821A1
公开(公告)日:2007-05-10
The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A
2B
adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents. Also provided are processes for the preparation of the compounds and their intermediates.
METHODS FOR THE SYNTHESIS OF UNSYMMETRICAL CYCLOALKYL SUBSTITUTED XANTHINES
申请人:Wang Guoquan
公开号:US20100004445A1
公开(公告)日:2010-01-07
The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A
2B
adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents. Also provided are processes for the preparation of the compounds and their intermediates.
The present invention provides compounds and pharmaceutical compositions that are selective antagonists of A
2B
adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.